Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.88 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.41 |
| ▸ | CPT2 | P23786 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL182589 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL182591 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL9838279 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL5930978 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL182590 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL17627562 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28706585 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL1462474 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL7369132 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL4818293 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116271340-A | Prefilled nanometer carbon suspension injection and preparation method thereof | 重庆莱美药业股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-108495860-A | A method of preparing intravenous injection of immunoglobulin from component III | K·黄 | 2018-09-04 | — | — | CN | claimed |
| CN-107921079-A | By the method for component III manufacture intravenous injection of immunoglobulin | K·黄 | 2018-04-17 | — | — | CN | claimed |
| US-20170233458-A1 | METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III | HOANG KIEU (US) | 2017-08-17 | — | — | US | claimed |
| WO-2016161421-A1 | A METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III | HOANG KIEU (US) | 2016-10-06 | — | — | WO | claimed |
| US-20160289300-A1 | METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III | HOANG KIEU (US) | 2016-10-06 | — | — | US | claimed |
| EP-0910387-B1 | APOPTOSIS ASSOCIATED PROTEIN BBK | IMMUNOGEN INC (US) | 2007-11-28 | — | — | EP | claimed |
| US-6057132-A | NUCLEOTIDE SEQUENCE CODING FOR A PROTEIN ASSOCIATED WITH DEFECTIVE CELL PROPAGATIVE STATES; FOR THE TREATMENT OF CELL DEGRADATIVE DEFECTS, CANCER, AUTOIMMUNE DISEASES AND NERVOUS SYSTEM DISORDERS | IMMUNOGEN, INC. (US) | 2000-05-02 | — | — | US | claimed |
| US-5998141-A | METHODS FOR DETERMINING WHETHER A SUBJECT HAS OR IS AT RISK OF DEVELOPING A DISEASE WHICH IS ASSOCIATED WITH A SPECIFIC ALLELE OF A POLYMORPHIC REGION OF AN SR-BI GENE, AND KITS FOR PERFORMING SUCH METHODS. | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-12-07 | — | — | US | claimed |
| EP-4689168-A1 | ULTRASENSITIVE MOLECULAR DETECTION VIA HYBRIDIZATION CHAIN REACTION | California Institute of Technology (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4673562-A1 | PROBES FOR MEASURING MOLECULAR PROXIMITY IN A SAMPLE | California Institute of Technology (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4114969-B1 | ANALYSIS OF TARGET MOLECULES WITHIN A SAMPLE VIA HYBRIDIZATION CHAIN REACTION | CALIFORNIA INST OF TECHN (US) | 2025-08-06 | — | — | EP | disclosed |
| EP-4592389-A2 | ANALYSIS OF TARGET MOLECULES WITHIN A SAMPLE VIA HYBRIDIZATION CHAIN REACTION | California Institute of Technology (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4582805-A2 | METHODS OF GENERATING LIBRARIES OF NUCLEIC ACID SEQUENCES FOR DETECTION VIA FLUORESCENT IN SITU SEQUENCING | President And Fellows Of Harvard College (US) | 2025-07-09 | — | — | EP | disclosed |
| WO-1993006738-A1 | NON-STICKY, FAT-CONTAINING CONFECTION | MERCK & CO., INC. (US) | 1993-04-15 | — | — | WO | disclosed |
| WO-1992021349-A1 | COMBINATIONS OF ALPHA-2 ADRENERGIC AGONISTS WITH ALPHA-3 ANTAGONISTS FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN, INC. (US) | 1992-12-10 | — | — | WO | disclosed |
| EP-0362290-A4 | CLONING OF MITE ALLERGENS | — | 1991-09-25 | — | — | EP | disclosed |
| US-4935240-A | Benzoylaminophenoxybutanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| EP-0362290-A1 | CLONING OF MITE ALLERGENS | INSTITUTE FOR CHILD HEALTH RESEARCH (AU) | 1990-04-11 | — | — | EP | disclosed |
| WO-1988010297-A1 | CLONING OF MITE ALLERGENS | PRINCESS MARGARET CHILDREN'S MEDICAL RESEARCH FOUN (AU) | 1988-12-29 | — | — | WO | disclosed |